Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)

Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology

2021, 33(3): 289-301. doi: 10.21147/j.issn.1000-9604.2021.03.01

Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan

2021, 33(3): 302-307. doi: 10.21147/j.issn.1000-9604.2021.03.02

Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia

Duo You, Danfeng Du, Xueke Zhao, Xinmin Li, Minfeng Ying, Xun Hu

2021, 33(3): 308-322. doi: 10.21147/j.issn.1000-9604.2021.03.03

Psychosomatic symptoms affect radiotherapy setup errors in early breast cancer patients

Yi He, Chang Gao, Ying Pang, Jixiang Chen, Lili Tang

2021, 33(3): 323-330. doi: 10.21147/j.issn.1000-9604.2021.03.04

Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma

Yihui Tang, Jianxian Lin, Junpeng Lin, Jiabin Wang, Jun Lu, Qiyue Chen, Longlong Cao, Mi Lin, Ruhong Tu, Changming Huang, Ping Li, Chaohui Zheng, Jianwei Xie

2021, 33(3): 331-342. doi: 10.21147/j.issn.1000-9604.2021.03.05

Pain threshold, anxiety and other factors affect intensity of postoperative pain in gastric cancer patients: A prospective cohort study

Hongyu Tan, Jin Wei, Shuo Li, Ling Yu, Hongwei Sun, Ke Ji, Yinkui Wang, Changlong Li

2021, 33(3): 343-351. doi: 10.21147/j.issn.1000-9604.2021.03.06

A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers

Yuting Wang, Minjie Wang, He Li, Kun Chen, Hongmei Zeng, Xinyu Bi, Zheng Zhu, Yuchen Jiao, Yong Wang, Jian Zhu, Hui Zhao, Xiang Liu, Chunyun Dai, Chunsun Fan, Can Zhao, Deyin Guo, Hong Zhao, Jianguo Zhou, Dongmei Wang, Zhiyuan Wu, Xinming Zhao, Wei Cui, Xuehong Zhang, Jianqiang Cai, Wanqing Chen, Chunfeng Qu

2021, 33(3): 352-363. doi: 10.21147/j.issn.1000-9604.2021.03.07

Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns

Zhenli Li, Geng Chen, Zhixiong Cai, Xiuqing Dong, Lei He, Liman Qiu, Yongyi Zeng, Xiaolong Liu, Jingfeng Liu

2021, 33(3): 364-378. doi: 10.21147/j.issn.1000-9604.2021.03.08

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer

Ke Zhao, Xiaomei Wu, Zhenhui Li, Yingyi Wang, Zeyan Xu, Yajun Li, Lin Wu, Su Yao, Yanqi Huang, Changhong Liang, Zaiyi Liu

2021, 33(3): 379-390. doi: 10.21147/j.issn.1000-9604.2021.03.09

Single-cell DNA methylome analysis of circulating tumor cells

Hengyu Chen, Zhe Su, Ruoyan Li, Ning Zhang, Hua Guo, Fan Bai

2021, 33(3): 391-404. doi: 10.21147/j.issn.1000-9604.2021.03.10

Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01 (a rituximab biosimilar) to reference rituximab in Chinese patients with CD20-positive B-cell lymphoma

Yuankai Shi, Qingyuan Zhang, Xiaohong Han, Yan Qin, Xiaoyan Ke, Hang Su, Li Liu, Jinxiang Fu, Jie Jin, Jifeng Feng, Xiaonan Hong, Xiaohong Zhang, Depei Wu, Bin Jiang, Xiaodong Dong

2021, 33(3): 405-416. doi: 10.21147/j.issn.1000-9604.2021.03.11

Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials

Wenlin Chen, Delin Liu, Penghao Liu, Ziren Kong, Yaning Wang, Yu Wang, Wenbin Ma

2021, 33(3): 417-432. doi: 10.21147/j.issn.1000-9604.2021.03.12